Koch Disruptive Technologies has announced an investment in Sight Diagnostics alongside global crowdfunding platform OurCrowd. Sight Diagnostics is a long time portfolio company of OurCrowd. The Series D funding raised a solid $ 71 million. Total funding now tops $ 124 million. A valuation of the Medtech firm was not provided.
Read more here.